Emergent BioSolutions Inc (EBS)
8.60
+0.88
(+11.40%)
USD |
NYSE |
Nov 18, 16:00
8.53
-0.07
(-0.81%)
After-Hours: 20:00
Emergent BioSolutions Profit Margin (Quarterly): 40.45% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 40.45% |
| June 30, 2024 | -114.1% |
| March 31, 2024 | 3.08% |
| December 31, 2023 | -18.34% |
| September 30, 2023 | -99.77% |
| June 30, 2023 | -78.90% |
| March 31, 2023 | -118.0% |
| December 31, 2022 | -20.74% |
| September 30, 2022 | -39.15% |
| June 30, 2022 | -23.96% |
| March 31, 2022 | -1.24% |
| December 31, 2021 | 28.08% |
| September 30, 2021 | -10.48% |
| June 30, 2021 | 1.24% |
| March 31, 2021 | 21.67% |
| December 31, 2020 | 33.12% |
| September 30, 2020 | 10.99% |
| June 30, 2020 | 24.98% |
| March 31, 2020 | -7.36% |
| December 31, 2019 | 13.95% |
| September 30, 2019 | 15.64% |
| June 30, 2019 | -4.70% |
| March 31, 2019 | -15.39% |
| December 31, 2018 | -1.43% |
| September 30, 2018 | 13.45% |
| Date | Value |
|---|---|
| June 30, 2018 | 24.60% |
| March 31, 2018 | -4.81% |
| December 31, 2017 | 19.09% |
| September 30, 2017 | 25.19% |
| June 30, 2017 | 5.79% |
| March 31, 2017 | 10.53% |
| December 31, 2016 | 35.92% |
| September 30, 2016 | 19.15% |
| June 30, 2016 | -18.72% |
| March 31, 2016 | 5.59% |
| December 31, 2015 | 24.71% |
| September 30, 2015 | 28.67% |
| June 30, 2015 | 15.51% |
| March 31, 2015 | -70.48% |
| December 31, 2014 | 32.40% |
| September 30, 2014 | 23.25% |
| June 30, 2014 | 5.75% |
| March 31, 2014 | -52.57% |
| December 31, 2013 | 17.77% |
| September 30, 2013 | 17.68% |
| June 30, 2013 | 15.98% |
| March 31, 2013 | -26.56% |
| December 31, 2012 | 21.66% |
| September 30, 2012 | 12.25% |
| June 30, 2012 | 14.36% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-118.0%
Minimum
Mar 2023
40.45%
Maximum
Sep 2024
-17.72%
Average
-4.30%
Median
Profit Margin (Quarterly) Benchmarks
| Geovax Labs Inc | -1.68K% |
| Tonix Pharmaceuticals Holding Corp | -503.6% |
| Abbott Laboratories | 15.48% |
| Insulet Corp | 14.25% |
| SIGA Technologies Inc | 13.43% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.94% |
| Return on Assets | -12.27% |
| Return on Invested Capital | -14.79% |
| Gross Profit Margin (Quarterly) | 56.80% |
| Operating Margin (Quarterly) | 22.73% |
| Return on Net Operating Assets | -14.69% |